{"id":19721,"date":"2024-11-27T17:23:42","date_gmt":"2024-11-27T22:23:42","guid":{"rendered":"https:\/\/www.progeriaresearch.org\/?page_id=19721"},"modified":"2024-12-02T12:37:36","modified_gmt":"2024-12-02T17:37:36","slug":"progerinin_trial","status":"publish","type":"page","link":"https:\/\/www.progeriaresearch.org\/ar\/progerinin_trial\/","title":{"rendered":"\u0627\u0644\u062a\u0633\u062c\u064a\u0644 \u0627\u0644\u0622\u0646: \u0645\u0639\u0644\u0648\u0645\u0627\u062a \u062c\u062f\u064a\u062f\u0629 \u0639\u0646 \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629"},"content":{"rendered":"

[et_pb_section fb_built=”1″ fullwidth=”on” disabled_on=”off|off|off” _builder_version=”4.16″ border_width_bottom=”55px” border_color_bottom=”#29327a” locked=”off” collapsed=”off” global_colors_info=”{}”][et_pb_fullwidth_header _builder_version=”4.27.2″ title_font=”||||||||” title_font_size=”55″ background_color=”#29327a” background_image=”https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/06\/header-Mio-Map-1-Dec-2017.jpg” background_position=”center_left” custom_padding=”7vw||7vw||true|” custom_padding_tablet=”” custom_padding_phone=”|56px||” custom_padding_last_edited=”on|desktop” title_font_size_tablet=”45px” title_font_size_phone=”40px” title_font_size_last_edited=”on|phone” z_index_tablet=”500″ custom_css_main_element=”background-position: center 18% !important;” global_colors_info=”{}”]<\/p>\n

<\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/i><\/b><\/span><\/h1>\n

<\/h1>\n

Enrolling Now: <\/i><\/b><\/span><\/h1>\n

New Clinical Trial Information<\/i><\/b><\/span><\/h1>\n

[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ use_custom_gutter=”on” gutter_width=”1″ specialty=”on” padding_left_1=”35px” padding_left_2=”35px” padding_2_tablet=”|||0px” padding_2_phone=”|||0px” padding_2_last_edited=”on|desktop” module_class_1=”sidebar-secondary-nav” module_class=”handprint-bg” _builder_version=”4.27.2″ background_image=”https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/04\/blue-handprint-only.png” parallax=”on” parallax_method=”off” inner_width=”100%” inner_max_width=”100%” custom_padding=”0|0px|54px|0px|false|false” z_index_tablet=”500″ border_width_top=”10px” border_color_top=”#8fd2ed” use_custom_width=”on” width_unit=”off” custom_width_percent=”100%” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_sidebar area=”et_pb_widget_area_1″ disabled_on=”on|on|off” admin_label=”Science Sidebar” module_class=”subpage-sidebars” _builder_version=”4.16″ animation_style=”fade” z_index_tablet=”500″ header_text_shadow_horizontal_length_tablet=”0px” header_text_shadow_vertical_length_tablet=”0px” header_text_shadow_blur_strength_tablet=”1px” body_text_shadow_horizontal_length_tablet=”0px” body_text_shadow_vertical_length_tablet=”0px” body_text_shadow_blur_strength_tablet=”1px” border_width_right=”5px” border_width_right_tablet=”5px” border_width_right_phone=”5px” box_shadow_horizontal_tablet=”0px” box_shadow_vertical_tablet=”0px” box_shadow_blur_tablet=”40px” box_shadow_spread_tablet=”0px” text_shadow_horizontal_length_tablet=”0px” text_shadow_vertical_length_tablet=”0px” text_shadow_blur_strength_tablet=”1px” locked=”off” global_colors_info=”{}”]
\n[\/et_pb_sidebar][\/et_pb_column][et_pb_column type=”3_4″ specialty_columns=”3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_row_inner custom_padding_last_edited=”on|phone” disabled_on=”on|on|” _builder_version=”4.16″ custom_padding=”39.4375px|35px|0px||false|false” custom_padding_tablet=”|35px||35px||true” custom_padding_phone=”” animation_direction=”top” z_index_tablet=”500″ global_colors_info=”{}”][et_pb_column_inner saved_specialty_column_type=”3_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”New Clinical Trial Information For Families and Their Physicians ” _builder_version=”4.27.2″ text_font_size=”18px” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||28px|||” hover_enabled=”0″ z_index_tablet=”500″ box_shadow_horizontal_tablet=”0px” box_shadow_vertical_tablet=”0px” box_shadow_blur_tablet=”40px” box_shadow_spread_tablet=”0px” global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

December 2, 2024 Posting:<\/em><\/strong><\/h4>\n

New Clinical Trial Information For Families and Their Physicians<\/em><\/strong><\/h4>\n

<\/strong><\/em><\/h4>\n

Enrollment in The New Progerinin Clinical Trial Has Begun<\/strong><\/em><\/h4>\n

Enrollment is now open for the progerinin trial! The title of this research study is: A Phase 2a, Randomized, Open-Label Study to Determine the Optimal Dose and Evaluate the Safety, Tolerability, and Pharmacokinetics of progerinin in Patients with Hutchinson-Gilford Progeria Syndrome (HGPS). The study site is Boston Children\u2019s Hospital (BCH). The study sponsor is the Korean-based company PRG Science & Technology (PRG S&T). PRF is collaborating with BCH and PRG S&T on this trial.\u00a0 As part of the collaboration, PRF will be arranging for travel to and from the trial site in Boston and lodging while in Boston. Trial information is also posted on the website clinicaltrials.gov<\/a><\/p>\n

[\/et_pb_text][et_pb_text admin_label=”Information For Patients with Progeria and their Doctors” _builder_version=”4.27.2″ text_text_color=”#000000″ text_font_size=”18px” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||19px|||” z_index_tablet=”500″ box_shadow_horizontal_tablet=”0px” box_shadow_vertical_tablet=”0px” box_shadow_blur_tablet=”40px” box_shadow_spread_tablet=”0px” global_colors_info=”{}”]<\/p>\n

Information For Patients with Progeria and their Doctors<\/em><\/strong><\/h5>\n